Vaxcell-Bio Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 25.9%.

Top 23 shareholders own 24.97% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
13.5%	Jaejoong Lee	3,100,047	₩44.7b	-16.4%	no data
5.99%	Junhaeng Lee	1,377,916	₩19.9b	-13.8%	no data
2.32%	The Vanguard Group, Inc.	532,478	₩7.7b	0.08%	no data
1.7%	Samsung Asset Management Company, Ltd.	391,702	₩5.6b	0%	0.02%
0.32%	Mirae Asset Global Investments Co., Ltd.	73,223	₩1.1b	0%	no data
0.13%	Charles Schwab Investment Management, Inc.	28,964	₩417.4m	-1.11%	no data
0.11%	Kyoung-Ja Lee	26,000	₩374.7m	0%	no data
0.11%	Midas Asset Management	25,000	₩360.3m	0%	0.03%
0.1%	Hyeon-kyoung Yun	23,800	₩343.0m	0%	no data
0.1%	Ji-ung Yang	23,800	₩343.0m	0%	no data
0.097%	KB Asset Management Co., Ltd.	22,233	₩320.4m	-1.17%	no data
0.087%	Chan-Yeong Lee	20,000	₩288.2m	-16.7%	no data
0.078%	Han-Byeol Lee	18,000	₩259.4m	0%	no data
0.078%	Seung-seok Hong	18,000	₩259.4m	0%	no data
0.078%	Geon-chan Lee	18,000	₩259.4m	0%	no data
0.075%	Ho-Yeong Lee	17,155	₩247.2m	-14.2%	no data
0.043%	State Street Global Advisors, Inc.	9,991	₩144.0m	3.56%	no data
0.024%	NH-Amundi Asset Management	5,526	₩79.6m	0%	no data
0.016%	Shinhan Asset Management Co., Ltd.	3,662	₩52.8m	0%	no data
0.013%	Korea Investment Management Co., Ltd.	3,093	₩44.6m	0%	no data
0.0043%	Sungchang Jeong	1,000	₩14.4m	0%	no data
0.0043%	Taekgeun Oh	988	₩14.2m	0%	no data
0.00072%	Invesco Capital Management LLC	166	₩2.4m	0%	no data